Loading market data...
15-min delayed
Live
Home Market News Stock Analysis Earnings Penny Stocks Crypto Economy Commodities Learn
Stocks About Contact

Maravai LifeSciences Holdings, Inc. Class A Common Stock

MRVI XNAS
$3.10 +0.02 (+0.65%) ▲ 15-min delayed
Open
$3.07
High
$3.15
Low
$3.01
Volume
649.1K
Market Cap
$449.57M

About Maravai LifeSciences Holdings, Inc. Class A Common Stock

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 550 Website →

Key Financials

Period Revenue Net Income EPS
Q3 2025 $41.63M $-45,057,000 $-0.18
Q2 2025 $47.40M $-69,837,000 $-0.27
Q1 2025 $46.85M $-52,853,000 $-0.21
FY 2024 $259.19M $-259,622,000 $-1.05

Get MRVI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Maravai LifeSciences Holdings, Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.